Search Results - Nina Horowitz
- Showing 1 - 4 results of 4
-
1
413 IBR403, a novel small molecule, enables scalable manufacturing of HSC-derived natural killer cells for cancer immunotherapy by Nina Horowitz, Shyama Chaganti, Bauer LeSavage, Stefanie Mauer, James Liu, Peretz Partensky, Jesse Cotari
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
2
T cell-mediated curation and restructuring of tumor tissue coordinates an effective immune response by John W. Hickey, Maximillian Haist, Nina Horowitz, Chiara Caraccio, Yuqi Tan, Andrew J. Rech, Marc-Andrea Baertsch, Xavier Rovira-Clavé, Bokai Zhu, Gustavo Vazquez, Graham Barlow, Eran Agmon, Yury Goltsev, John B. Sunwoo, Markus Covert, Garry P. Nolan
Published in Cell Reports (2023-12-01)Get full text
Article -
3
Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer by Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michal Marczyk, Courtney Frederick, Trisha Burrello, Eiman Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L. Rimm, Lajos Pusztai
Published in npj Breast Cancer (2021-02-01)Get full text
Article -
4
Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer by Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Chagpar, Tristen Park, Michal Marczyk, Courtney Frederick, Trisha Burrello, Eiman Ibrahim, Tao Qing, Yalai Bai, Kim Blenman, David L. Rimm, Lajos Pusztai
Published in npj Breast Cancer (2022-02-01)Get full text
Article